Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

nimotuzumab

A humanized monoclonal antibody directed against the epidermal growth factor receptor (EGFR) with potential antineoplastic activity. Nimotuzumab binds to and inhibits EGFR, resulting in growth inhibition of tumor cells that overexpress EGFR. This agent may act synergistically with radiation therapy.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:Thera-CIM-hr3
TheraCim hR3
Foreign brand name:Theraloc
Code name:H-R3
hR3
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search